1Daimon T,Nakanno M.Immunohistochemical localization of thrombomodulin in the stratified epithelium of the rat is restricted to the keratinizing epidermis[J].Histochem Cell,Biol[J].1999,112(6):437-442.
2Wada H,Wakita Y,Nakase T,et al.Increased plasmasoluble fibrin monomer levels in patients with disseminated intravascular coagulation[J].Am J Hematol,1996,51(4):255-260.
3Wada H,Sakuragawa N,Shiku H.Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemia patients[J].Semin Thromb Hemost,1998,24(3):293-297.
4Wada H,Mori Y,Shimura M,et al.Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purura patient s with severe vascular endothelial cell injuries[J].Am J Hemtol,1998,58(3):189-194.
5Watanabe R,Wada H,Miura Y,et al.Plasma levels of total plasminogen activator inhibitor-I(PAI-I)and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura[J].Clin Appl Thromb Hemost,2001,7(3):229-233.
6Bos R,Laterveer-Vreeswijk GH,Lockwood D,et al.A new enzyme immunoassay for soluble fibrin in plasma,with a high discriminating power for thrombotic disorders[J].Thromb Haemost,1999,81(1):54-59.
7Okajima K,Uchiba M,Murakami K,et al.Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation[J].Am J Hematol,1996,51(3):186-191.
8Chan JC.Gene targeting in hemostasis.Tissue factor pathway inhibitor[J].Front Biosci,2001,6:D216-221.
9Ohkura N,Soe G,Kohno I,et al.Monoclonal antibody specific for tissue factor pathway inhibitorfactor complex:its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation[J].Blood Coagul Fibrinolysis,1999,10(6):309-319.
10Shimura M,Wada H,Nakasaki T,et al.Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation[J].Am J Hematol,1999,60(2):94-98.
